Group One Trading’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,559
| Closed | -$3.98K | – | 8553 |
|
|
2023
Q2 | $1.49K | Hold |
4,559
| – | – | ﹤0.01% | 7171 |
|
|
2023
Q1 | $1.96K | Sell |
4,559
-1,500
| -25% | -$791 | ﹤0.01% | 6621 |
|
|
2022
Q4 | $3.21K | Buy |
6,059
+1,045
| +21% | +$663 | ﹤0.01% | 6513 |
|
|
2022
Q3 | $4K | Sell |
5,014
-11,500
| -70% | -$13K | ﹤0.01% | 6978 |
|
|
2022
Q2 | $19K | Sell |
16,514
-11,700
| -41% | -$14.9K | ﹤0.01% | 6345 |
|
|
2022
Q1 | $58K | Sell |
28,214
-39,229
| -58% | -$93.3K | ﹤0.01% | 5987 |
|
|
2021
Q4 | $194K | Sell |
67,443
-1,886
| -3% | -$6.98K | ﹤0.01% | 5117 |
|
|
2021
Q3 | $294K | Sell |
69,329
-43,183
| -38% | -$193K | ﹤0.01% | 4773 |
|
|
2021
Q2 | $595K | Buy |
112,512
+81,172
| +259% | +$390K | ﹤0.01% | 4025 |
|
|
2021
Q1 | $146K | Buy |
31,340
+23,411
| +295% | +$106K | ﹤0.01% | 5307 |
|
|
2020
Q4 | $26K | Sell |
7,929
-33,468
| -81% | -$127K | ﹤0.01% | 5383 |
|
|
2020
Q3 | $137K | Buy |
+41,397
| New | +$152K | ﹤0.01% | 3954 |
|
|
2020
Q2 | – | Sell |
-22,446
| Closed | -$106K | – | 6320 |
|
|
2020
Q1 | $86K | Buy |
22,446
+11,489
| +105% | +$53.4K | ﹤0.01% | 3405 |
|
|
2019
Q4 | $66K | Sell |
10,957
-34,483
| -76% | -$236K | ﹤0.01% | 3879 |
|
|
2019
Q3 | $344K | Sell |
45,440
-66,089
| -59% | -$745K | ﹤0.01% | 2656 |
|
|
2019
Q2 | $1.51M | Buy |
111,529
+73,351
| +192% | +$847K | 0.01% | 1306 |
|
|
2019
Q1 | $207K | Sell |
38,178
-536
| -1% | -$2.61K | ﹤0.01% | 2675 |
|
|
2018
Q4 | $115K | Sell |
38,714
-10,090
| -21% | -$55.3K | ﹤0.01% | 3090 |
|
|
2018
Q3 | $398K | Buy |
48,804
+31,928
| +189% | +$245K | ﹤0.01% | 2474 |
|
|
2018
Q2 | $164K | Sell |
16,876
-19,459
| -54% | -$199K | ﹤0.01% | 3203 |
|
|
2018
Q1 | $316K | Buy |
+36,335
| New | +$392K | ﹤0.01% | 2413 |
|
|
2017
Q3 | – | Sell |
-4,596
| Closed | -$48.6K | – | 5286 |
|
|
2017
Q2 | $78K | Buy |
+4,596
| New | +$91.4K | ﹤0.01% | 3271 |
|
Group One Trading's ZYNE Position: Q3 2023 in Review
Group One Trading sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2023, closing a stake of 4,559 shares — an estimated $3.98K sold.
Group One Trading first reported a position in ZYNE in Q2 2017 and held it in 22 quarters. The position peaked at $1.51M in Q2 2019. 43 funds tracked by Wall St. Rank hold ZYNE as of Q3 2023.
- Group One Trading reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2023 after selling out during the quarter.
- Group One Trading sold 4,559 Zynerba Pharmaceuticals, Inc shares in Q3 2023, an estimated $3.98K.
- Group One Trading first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2017 and held it in 22 quarters.
- Group One Trading's Zynerba Pharmaceuticals, Inc position peaked at $1.51M in Q2 2019.
- 43 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2023.
Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.